Introduction
Traditionally, secondary metabolites produced by microorganisms, and especially terrestrial actinomycetes, are remarkable sources of lead compounds for drug discovery (1). However, the rate at which new metabolites from terrestrial actinomycetes are discovered has decreased, and the rate of reisolation of known compounds has increased due to the replication of isolating microbial strains (2) . Compared to terrestrial actinomycetes, marine actinomycetes are relatively unexploited sources (3) . The fact that marine Streptomyces in particular are rich in novel bioactive metabolites is just becoming apparent (4) (5) (6) . Moreover, genetic analysis has indicated that some marine-derived Streptomyces form an independent clade (7) . The present study obtained four metabolites, i.e. cyclo(D)-Pro-(D)-Val (1) (8) , cyclo(D)-Pro-(D)-Leu (2) (8), oxoprothracarcin (3) (9-11), and limazepine A (4) (12) (Figure 1 ), from the metabolites of marine Streptomyces sp. M10946. Reported here are the isolation, structural determination, and antitumor and antibacterial activities of compounds 1-4.
Materials and Methods

General
NMR spectra were recorded on a Bruker Advance 600 spectrometer (Bruker, Fällanden, Switzerland) at 600/150 MHz. Mass spectra were obtained on ABI-4000 mass spectrometers (AB SCIEX, Framingham, MA, USA). An Agilent 1260 HPLC system (Agilent, Santa Clara, CA, USA) with a C-18 column (9.4 × 250 mm, 5 μm) was also used. Column chromatography included a RP-18 (Merck, Darmstadt, Germany) column and a Sephadex LH-20 column (GE healthcare, Uppsala, Sweden). TLC analyses were performed with precoated silica gel GF254 plates (0.20-0.25 mm, Qingdao Marine Chemical Factory, Qingdao, China). All general chemical reagents were purchased from Sinopharm Chemical Reagent Company (Beijing, China). 
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Microorganism sample
The 
Tumor cell lines
The MDA-MB-231 human breast cancer cell line and A549 human lung cancer cell line were purchased from the American Type Culture Collection (ATCC). All cells were maintained in DMEM with 10% fetal bovine serum (FBS, Gibco) in a humidified CO 2 incubator in 5% CO 2 at 37°C.
Fermentation and isolation
Fermentation took place for 14 d on YMG (10 L) agar plates at 28°C. The culture was diced and extracted with AcOEt/MeOH/AcOH (80:15:5). The organic solution was collected through filtration and the remaining agar residue was extracted exhaustively with the same solvent until the filtrate was colorless. Upon evaporation, the combined filtrate yielded a crude extract. The crude extract was partitioned between water and EtOAc (1:1, v/v) until the EtOAc layer was colorless. The EtOAc extract was partitioned between MeOH and petroleum ether. The MeOH layer was concentrated in a vacuum to yield a brown syrupy extract (1.4 g). The extract was subjected to MPLC (30 g RP-18 silica gel; 30%, 50%, 70%, and 100% MeOH, 1 L for each gradient) to yield 4 fractions, Fr. a-d. Fraction a (192 mg) was separated by column chromatography (CC) over Sephadex LH-20 (in MeOH) to yield one subfraction (Fr.a.1). Fr.a.1 (33 mg) was subjected to HPLC (C-18 column, 9.4 × 250 mm, 5 μm; 30% MeOH) to yield 1 (3 mg) and 2 (9 mg). Fraction b (240 mg) was subjected to CC over Sephadex LH-20 (in MeOH) to yield two subfractions (Fr.b.1 and Fr.b.2). Fr.b.1 (53mg) was purified by Sephadex LH-20 (in MeOH) to yield 3 (36 mg). Fr.b.2 (28 mg) was purified by recrystallization (MeOH) to yield 4 (20 mg).
Biological study
The cytotoxicity of compounds 1-4 was assessed using a 3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide (MTT) cell survival assay (13), Briefly, 3000 -5000 MDA-MB-231 and A549 cells were seeded in 96-well plates overnight and treated three times with increasing concentrations of compounds. After the cells were treated for 72 h, a 10-μL of aliquot of MTT solution (5 mg/mL) was added and cells were incubated for 4 h at 37°C. Two hundred μL of DMSO was then added to dissolve formazan crystals. The color density was measured with a microplate reader (M-3350, BioRad) at 570 nm. Growth inhibition rates were calculated as follows: (A570 control cells -A570 treated cells )/A570 control cells × 100%.
The antibacterial activity of compounds 1 -4 was tested against Bacillus subtilis (CMCC (B) 63501), Bacillus pumilus (CMCC (B) 63202), and Penicillium avellaneum (UC 4376) using the filter paper method. Growth inhibition was calculated as the radius of the inhibition zone.
Results and Discussion
Elucidation of the structures of compounds
ESI-MS revealed the molecular weight of compound 1 to be 196 Da. The 13 C-NMR spectrum of 1 (Table  1) (9) indicated that 3 had a disubstituted benzene. Next, the HMBC correlation from CH(6) to C(5) indicated the presence of fragment 3A (Figure 3 ). The double bond was assigned at C(2) and CH (12) in accordance with the HMBC correlation (Figure 3 ) of δH 1.68 CH 3 (13) with δC 127.5 CH(12) and δH 2.59, δH 3.28 CH 2 (1) and that of δH 4.03, δH 4.24 CH 2 (3) with δC 134.5 C(2). The HMBC correlation from CH(11a) and CH 2 (1) to C(5), in combination with the 1 H-1 H COSY correlation between CH 2 (1)↔CH(11a), indicated the presence of fragment 3B (Figure 3) . Therefore, compound 3 was determined and 29.9 indicated the presence of three CH 2 groups. Furthermore, the HMBC spectrum showed that CH 2 (5) was correlated with C(7). In combination with the 1 H-1 H COSY correlation between CH 2 (3)↔CH(4)↔CH (5), these findings indicated the presence of fragment 1B (Figure 2 ), which was a proline residue ( Figure 2 ). The spectral data for 1 were consistent with those reported in the literature (8) . Thus, compound 1 was determined to be cyclo(D)-Pro-(D)-Val. ESI-MS revealed the molecular weight of compound 2 to be 210 Da. The chemical structure of 2 was determined by comparing NMR data for 2 with those for 1. Both compounds had similar spectroscopic data (Table 1) , except for C(11), C(12), and C(13). ESI-MS data revealed the molecular weight of compound 3 to be 242 Da. The 1 H-NMR spectrum of 3 (Table 2 ) displayed 14 signals. The 13 C-NMR spectrum of 3 (Table 2 ) displayed 14 signals for one methyl, two methylenes, six methines, and five quaternary carbon atoms, including two carbonyl groups (with one at δC 172.2 C(11) and the other at δC 167.7 C (5)). This suggested the presence of two acylamino groups as in compounds 1 and 2. The 1 H-NMR signal at δH 5.50 (1H, m) and 13 C-NMR signals at δC 119.1 and 134.5 suggested a trisubstituted (13) and CH 2 (1)↔CH(11a) indicated a C=C bond between C(2) and C(3). The 1 H-1 H COSY correlation between CH(6)↔CH (7), and the 13 C-NMR signals at δC 150.4 C(8) and 137.1 C(9) indicated the presence of a methoxyl group at C(8) and a hydroxyl group at C(9). The spectral data for compound 4 were identical to those of limazepine A reported in the literature (8).
Biological study
At a concentration of 10 μM, compounds 1 -4 inhibited the growth of MDA-MB-231 cells at rates of 5.2%, 6.3%, 10.2%, and 3.8%, and they inhibited the growth of A549 cells at rates of 18.4%, 19.6%, 7.3%, and 0.7%. The antibacterial activity of compounds 1 -4 was tested against Bacillus subtilis (CMCC (B) 63501), Bacillus pumilus (CMCC (B) 63202), and Penicillium avellaneum (UC 4376) using the filter paper method. Activity of each compound was tested twice at a concentration of 1.0 mg/mL with a loading volume of 20 μL. Results indicated that compounds 1 -4 had no effect on the growth of the bacteria tested at 20 μg/disc.
Conclusions and perspectives
Genetic analysis indicated that some marine Streptomyces form an independent clade (7), so marine Streptomyces was surmised to potentially be rich in novel secondary metabolites. The present study succeeded in isolating only one new compound, which suggests that fermentation medium screening and/or genetic manipulation are needed to encourage the production of secondary metabolites in marine Streptomyces. However, compound 3 was isolated with a high yield (36 mg/10 L) and could be used as a lead compound for structural modifications.
